Pregunta 1
Pregunta
Drug: “Substances that produce a change in cellular or physiological functioning of humans.”
Pregunta 2
Pregunta
For Drugs... End-point of the supply chain drives demand
Pregunta 3
Pregunta
The five factors influencing prescribing behavior are:
Respuesta
-
Education
-
Colleagues or other health care providers
-
Control and regulatory mechanisms
-
Demands by consumers and society
-
Promotional activities by drug manufacturers
-
Kickbacks from pharmaceutical companies
Pregunta 4
Pregunta
What are the two main acts used by the FDA to control pharmaceuticals?
Respuesta
-
Food, Drug, and Cosmetic Act
-
Public Health Service Act
-
HIPPA Act
-
Omnibus Act
Pregunta 5
Pregunta
Non-FDA-approved (“off-label”) indications are uses of a product that were not approved by the FDA, but have shown value after approval based on postmarketing research.
Pregunta 6
Pregunta
Non-FDA-approved indications can be promoted by the manufacturer.
Pregunta 7
Pregunta
The FDA started allowing direct advertising in what year?
Pregunta 8
Pregunta
Drug prices: Suggested price determined by manufacturer is usually a different price (much lower) that is actually paid out-of-pocket by most consumers based on their insurance plan.
Pregunta 9
Pregunta
This phase in the drug development is tested on non-human subject
Respuesta
-
Phase 0
-
Phase 1
-
Phase 2
-
Phase 3
-
Phase 4
Pregunta 10
Pregunta
Which of the phases allow human trail?
Respuesta
-
Phase 0
-
Phase 1
-
Phase 2
-
Phase 3
Pregunta 11
Pregunta
Phase 1 trials allow 20-80 people (for safety, dosing range, and side effects). Phase 2 trials allow 100-300 people (for effective and further evaluation of safety). Phase 3 trials allow how many people (to confirm effectiveness, monitor side effects, and compared it to commonly used treatments)?
Respuesta
-
500-1000
-
1000-3000
-
4000-5000
Pregunta 12
Pregunta
Phase 4 trial - post marketing studies delineate additional information including the drug's risks, benefits, and optimal use.